uthr market cap compared with its competior

United Therapeutics Corporation (UTHR) has a market capitalization of $15.48 billion as of August 23, 2024. When compared to its competitors:

1. Actelis Networks (ASNS): Actelis has a much smaller market cap of $9.57 million.
2. Biogen (BIIB): Biogen has a market cap of $29.86 billion.
3. Amgen (AMGN): Amgen's market cap is significantly larger at $176.67 billion.
4. Gilead Sciences (GILD): Gilead Sciences has a market cap of $95.52 billion.

This comparison indicates that UTHR's market cap is relatively smaller compared to Amgen and Gilead Sciences but larger than that of Biogen and Actelis Networks. It suggests that UTHR is a smaller company in terms of market value but is still a substantial player in the industry.